Satoru Yasuda

Title: Satoru Yasuda: Innovator in Antibody-Drug Conjugates

Introduction

Satoru Yasuda is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibody-drug conjugates. With a total of three patents to his name, Yasuda's work has the potential to impact cancer treatment significantly.

Latest Patents

Yasuda's latest patents include a protein that recognizes a drug moiety of an antibody-drug conjugate. This invention allows for the quantification of the concentration of the antibody-drug conjugate in plasma after administration in mammals. Another notable patent is a method for identifying subjects suitable for receiving a medicament containing an anti-hTROP2 antibody. This method involves evaluating the expression levels of specific genes in biological samples from cancer patients.

Career Highlights

Throughout his career, Satoru Yasuda has worked with notable companies such as Daiichi Sankyo Company, Limited and Tokyo Juki Industrial Co., Ltd. His experience in these organizations has contributed to his expertise in the field of drug development and biotechnology.

Collaborations

Yasuda has collaborated with several professionals in his field, including Hideo Asao and Daisuke Okajima. These collaborations have likely enhanced his research and development efforts.

Conclusion

Satoru Yasuda is a key figure in the innovation of antibody-drug conjugates, with a focus on improving cancer treatment methodologies. His patents and collaborations reflect his commitment to advancing medical science.